Citius Pharmaceuticals Statistics

Total Valuation

CTXR has a market cap or net worth of $20.09 million. The enterprise value is $2.50 million.

Market Cap	20.09M
Enterprise Value	2.50M

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025, after market close.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CTXR has 7.73 million shares outstanding. The number of shares has increased by 9.86% in one year.

Current Share Class	7.73M
Shares Outstanding	7.73M
Shares Change (YoY)	+9.86%
Shares Change (QoQ)	+9.29%
Owned by Insiders (%)	1.26%
Owned by Institutions (%)	11.60%
Float	7.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.22
P/TBV Ratio	1.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.75, with a Debt / Equity ratio of 0.00.

Current Ratio	6.75
Quick Ratio	4.31
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.49% and return on invested capital (ROIC) is -27.68%.

Return on Equity (ROE)	-41.49%
Return on Assets (ROA)	-24.74%
Return on Capital (ROIC)	-27.68%
Revenue Per Employee	n/a
Profits Per Employee	-$1.81M
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CTXR has paid $576,000 in taxes.

Income Tax	576,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.74% in the last 52 weeks. The beta is 1.36, so CTXR's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	-86.74%
50-Day Moving Average	6.51
200-Day Moving Average	14.51
Relative Strength Index (RSI)	29.27
Average Volume (20 Days)	551,370

Short Selling Information

The latest short interest is 603,742, so 7.81% of the outstanding shares have been sold short.

Short Interest	603,742
Short Previous Month	13.45M
Short % of Shares Out	7.81%
Short % of Float	7.91%
Short Ratio (days to cover)	13.22

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.07M
Pretax Income	-35.62M
Net Income	-39.77M
EBITDA	-41.07M
EBIT	-41.07M
Earnings Per Share (EPS)	-$6.11

Full Income Statement

Balance Sheet

The company has $17.91 million in cash and $320,011 in debt, giving a net cash position of $17.59 million or $2.28 per share.

Cash & Cash Equivalents	17.91M
Total Debt	320,011
Net Cash	17.59M
Net Cash Per Share	$2.28
Equity (Book Value)	86.28M
Book Value Per Share	11.85
Working Capital	23.85M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-29.09M
Capital Expenditures	n/a
Free Cash Flow	-29.09M
FCF Per Share	-$3.76

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTXR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.86%
Shareholder Yield	-9.86%
Earnings Yield	-197.93%
FCF Yield	-144.79%

Analyst Forecast

The average price target for CTXR is $100.00, which is 3,746.15% higher than the current price. The consensus rating is "Buy".

Price Target	$100.00
Price Target Difference	3,746.15%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 26, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Nov 26, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1